Sun, Sep 21, 2014, 5:39 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Boston Scientific Corporation Message Board

  • learnigisdkey learnigisdkey Sep 18, 2012 9:22 AM Flag

    A down grade-sort of...Let's see how market reacts.

    Leerink Swann downgraded Boston Scientific (NYSE: BSX) from Outperform to Market Perform with a price target of $6.00.

    The firm comments, "With a strong free cash flow yield of ~11%, BSX shares could represent an attractive total return vehicle to long-term focused value investors. In the near-term, with ~50% of sales facing market declines and share losses, we think shares could trade in a tight range. As improving product mix and recent restructuring initiatives begin to bear fruit, BSX could potentially drive double-digit EPS growth in 2014 and beyond. We don’t expect BSX to return to top-line growth until 2014 at the earliest and see limited upside to shares from current levels pending clarity on: (1) New CEO Mike Mahoney’s growth strategy once he starts on Nov. 1; (2) BSX's capital allocation strategy; (3) Long-term sales growth drivers; and, (4) Timing and extent of potential MedTech market recovery."

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • If and a big if at that, if BSX closes green today it would be the most bullish sign possible. Overcoming a "mild" down grade ($6 target) and shaking out the weak hands which is always done before the take off, there is ever going to be one. All we (i) can do is wait. I remain bullish.

      Please becareful entering the Casino. lol

      Sentiment: Strong Buy

 
BSX
12.41-0.01(-0.08%)Sep 19 4:02 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.